Objective: This study aims to evaluate the subjective and objective outcomes of the transobturator tape (TOT) procedure performed to treat stress urinary incontinence and to determine the efficacy and safety of the TOT procedure when used along with vaginal surgery. Methods: This is a prospective review of 24 women who had the TOT procedure done only due to stress incontinence; 22 women who underwent concomitant TOT and pelvic floor repair; and 20 women who received concurrent TOT, transvaginal hysterectomy, and sacrospinous ligament fixation. Results: When compared to the patients who had TOT with pelvic floor repair, the patients who underwent TOT with hysterectomy declared to have more dyspareunia (p = 0.008) and they were found to have significantly higher post-void residual volume (p = 0.014). When compared to the patients who had only TOT, the patients who underwent TOT with hysterectomy claimed to have more pelvic pain (p = 0.012) and significantly higher post-void residual volume (p = 0.020). Conclusion: The TOT procedure results in moderately high objective cure rates, and concurrent application of pelvic floor repair or transvaginal hysterectomy does not affect these rates. The relatively higher incidences for voiding problems and pelvic pain in women who underwent TOT, hysterectomy, and sacropinous fixation simultaneously suggest that the extent of surgery directly correlates with the severity of postoperative complications.

1.
Bardsley A: An overview of urinary incontinence. Br J Nurs 2016; 25:S14–S21.
2.
Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI, Milsom I: Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm 2014; 20: 130–140.
3.
Lamin E, Parrillo LM, Newman DK, Smith AL: Pelvic floor muscle training: underutilization in the USA. Curr Urol Rep 2016; 17: 10.
4.
Medina CA, Costantini E, Petri E, Mourad S, Singla A, Rodríguez-Colorado S, Ortiz OC, Doumouchtsis SK: Evaluation and surgery for stress urinary incontinence: a FIGO working group report. Neurourol Urodyn 2017; 36: 518–528.
5.
Lavelle ES, Zyczynski HM: Stress urinary incontinence: comparative efficacy trials. Obstet Gynecol Clin North Am 2016; 43: 45–57.
6.
Schimpf MO, Rahn DD, Wheeler TL, Patel M, White AB, Orejuela FJ, El-Nashar SA, Margulies RU, Gleason JL, Aschkenazi SO, Mamik MM, Ward RM, Balk EM, Sung VW; Society of Gynecologic Surgeons Systematic Review Group: Sling surgery for stress urinary incontinence in women: a systematic review and metaanalysis. Am J Obstet Gynecol 2014; 211: 71.e1–71.e27.
7.
Mostafa A, Agur W, Abdel-All M, Guerrero K, Lim C, Allam M, Yousef M, N’Dow J, Abdel-fattah M: A multicentre prospective randomised study of single-incision mini-sling (Ajust®) versus tension-free vaginal tape-obturator (TVT-OTM) in the management of female stress urinary incontinence: pain profile and short-term outcomes. Eur J Obstet Gynecol Reprod Biol 2012; 165: 115–121.
8.
Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, Kraus SR, Chai TC, Lemack GE, Dandreo KJ, Varner RE, Menefee S, Ghetti C, Brubaker L, Nygaard I, Khandwala S, Rozanski TA, Johnson H, Schaffer J, Stoddard AM, Holley RL, Nager CW, Moalli P, Mueller E, Arisco AM, Corton M, Tennstedt S, Chang TD, Gormley EA, Litman HJ; Urinary Incontinence Treatment Network: Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 2010; 362: 2066–2076.
9.
Tanuri AL, Feldner PC Jr, Bella ZI, Castro RA, Sartori MG, Girão MJ: Retropubic and transobturator sling in treatment of stress urinary incontinence. Rev Assoc Med Bras 2010; 56: 348–354.
10.
Schierlitz L, Dwyer P, Roasmilia A, Murray C, Thomas E, Fitzgerald E, Hiscock R, De Souza A: A randomized controlled study to compare tension free vaginal tape (TVT) and MONARC trans-obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD). Int Urogynecol J 2007; 18(suppl 1):S19.
11.
Lee KS, Han DH, Choi YS, Yum SH, Song SH, Doo CK, Choo MS: A prospective trial comparing tension-free vaginal tape and transobturator vaginal tape inside-out for the surgical treatment of female stress urinary incontinence: 1-year followup. J Urol 2007; 177: 214–218.
12.
Falkert A, Seelbach-Gobel B: TVT versus TOT for surgical treatment of female stress urinary incontinence. Int J Gynaecol Obstet 2007; 96: 40–41.
13.
Giberti C, Gallo F, Cortese P, Schenone M: Transobturator tape for treatment of female stress urinary incontinence: objective and subjective results after a mean follow-up of two years. Urology 2007; 69: 703–707.
14.
Liapis A, Bakas P, Giner M, Creatsas G: Tension-free vaginal tape versus tension-free vaginal tape obturator in women with stress urinary incontinence. Gynecol Obstet Invest 2006; 62: 160–164.
15.
Neuman M: Transvaginal suture placement for bleeding control with the tension-free vaginal tape procedure. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17: 176–177.
16.
Debodinance P: Trans-obturator urethral sling for surgical correction of female stress urinary incontinence: outside-in (Monarc) versus inside-out (TVT-O). Are both ways safe? J Gynecol Obstet Biol Reprod (Paris) 2006; 35: 571–577.
17.
Law TS, Cheung RY, Chung TK, Chan SS: Efficacy and outcomes of transobturator tension-free vaginal tape with or without concomitant pelvic floor repair surgery for urinary stress incontinence: five-year follow-up. Hong Kong Med J 2015; 21: 333–338.
18.
Jelovsek JE: Predicting urinary incontinence after surgery for pelvic organ prolapse. Curr Opin Obstet Gynecol 2016; 28: 399–406.
19.
Alas AN, Chinthakanan O, Espaillat L, Plowright L, Davila GW, Aguilar VC: De novo stress urinary incontinence after pelvic organ prolapse surgery in women without occult incontinence. Int Urogynecol J 2017; 28: 583–590.
20.
Swift SE, Yoon EA: Test-retest reliability of the cough stress test in the evaluation of urinary incontinence. Obstet Gynecol 1999; 94: 99–102.
21.
Aydemir O, Guvenir T, Kuey L, Kultur S: Hastane anksiyete ve depresyon olcegi Turkce formunun guvenilirligi ve gecerliligi. Turk Psikiyatri Dergisi 1977; 8: 280–287.
22.
Kocyigit H, Aydemir O, Olmez N, Memis A: Kisa Form-36 (KF-36)’nin Turkce versiyonunun guvenilirligi ve gecerliligi. Ilaç ve Tedavi Dergisi 1999; 12: 102–106.
23.
Abdel-Fattah M, Mostafa A, Familusi A, Ramsay I, N’dow J: Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3-year outcomes from the Evaluation of Transobturator Tapes study. Eur Urol 2012; 62: 843–851.
24.
Athanasiou S, Grigoriadis T, Zacharakis D, Skampardonis N, Lourantou D, Antsaklis A: Seven years of objective and subjective outcomes of transobturator (TVT-O) vaginal tape: why do tapes fail? Int Urogynecol J 2014; 25: 219–225.
25.
Angioli R, Plotti F, Muzii L, Montera R, -Panici PB, Zullo MA: Tension-free vaginal tape versus transobturator suburethral tape: -five-year follow-up results of a prospective, randomised trial. Eur Urol 2010; 58: 671–677.
26.
Yonguc T, Gunlusoy B, Degirmenci T, Kozacioglu Z, Bozkurt IH, Arslan B, Minareci S, Yilmaz Y: Are the outcomes of transobturator tape procedure for female stress urinary incontinence durable in long-term follow-up? Int Urol Nephrol 2014; 46: 1295–1300.
27.
Bostanci MS, Ozden S, Unal O, Cevrioglu AS, Akdemir N, Albayrak M: Investigation of the efficacy of transobturator tape (TOT) surgery in stress urinary incontinence. North Clin Istanb 2015; 1: 137–140.
28.
Thakar R: Is the uterus a sexual organ? Sexual function following hysterectomy. Sex Med Rev 2015; 3: 264–278.
29.
Tsivian A, Benjamin S, Tsivian M, Rikover M, Mogutin B, Korczak D, Sidi AA: Transobturator tape procedure with and without concomitant vaginal surgery. J Urol 2009; 182: 1068–1071.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.